Mustafa Khasraw

12.7k citations

194 papers · 5.8k indexed · 3 hit papers · h-index 34

Impact in

Genetics top 0.2%
- Glioma Diagnosis and Treatment
Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies

Papers in

Genetics 87
- Glioma Diagnosis and Treatment 83
Oncology 98
- Cancer Immunotherapy and Biomarkers 21
- Lung Cancer Research Studies 21
- PARP inhibition in cancer therapy 13

Co-authors: David M. Ashley Aaron C. Tan Henry S. Friedman Giselle Y. López Michael D. Malinzak Brent A. Hanks John H. Strickler Nick Pavlakis
Journals: Neuro-Oncology (29 papers)Journal of Clinical Oncology (24 papers)Clinical Cancer Research (7 papers)Cochrane Database of Systematic Reviews (6 papers)Neuro-Oncology Advances (6 papers)
Partner nations: Australia United States Singapore

In The Last Decade

Mustafa Khasraw

182 papers receiving 5.8k citations

Hit Papers

align trajectories log scale

High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types 2021 · 672 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Annals of Oncology
2020 CA A Cancer Journal for Clinicians
2020 Clinical Cancer Research

Peers

Countries citing papers authored by Mustafa Khasraw

Since Specialization

Citations

This map shows the geographic impact of Mustafa Khasraw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mustafa Khasraw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mustafa Khasraw more than expected).

Fields of papers citing papers by Mustafa Khasraw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mustafa Khasraw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mustafa Khasraw. The network helps show where Mustafa Khasraw may publish in the future.

Co-authors

The 25 scholars most cited alongside Mustafa Khasraw, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mustafa Khasraw Line = papers co-authored together Mustafa Khasraw links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	IL-7–mediated expansion of autologous lymphocytes increases CD8+ VLA-4 expression and accumulation in glioblastoma models Journal of Clinical Investigation ·Kirit Singh, Kelly Hotchkiss, Sarah Cook, Pamy Noldner, Ying Zhou, Eliese Moelker, Chelsea Railton, Emily Blandford, Bhairavy Puviindran, Shannon E. Wallace, Pamela K. Norberg, Gary E. Archer, Beth H. Shaz, Katayoun Ayasoufi, John H. Sampson, Mustafa Khasraw, Peter E. Fecci	2025	1
2	NIMG-77. MRI PHENOMENON OF PUNCTATE ENHANCING LESIONS IN PATIENTS TREATED WITH IDH INHIBITORS Neuro-Oncology ·Michal Nisnboym Ziv, Mallika Patel, Maria Minor, Margaret Johnson, Kristen A. Batich, Justin Low, Madison L Shoaf, Mustafa Khasraw, Annick Desjardins, Henry S. Friedman, David M. Ashley, Katherine B. Peters	2024	0
3	Chimeric antigen receptor T-cell therapy in patients with malignant glioma—From neuroimmunology to clinical trial design considerations Neuro-Oncology ·Marco Gallus, Jacob S. Young, Sarah Cook Quackenbush, Mustafa Khasraw, John de Groot, Hideho Okada	2024	3
4	Interdependencies of the Neuronal, Immune and Tumor Microenvironment in Gliomas Cancers ·Alexander Yuile, Joe Wei, Aditya Mohan, Kelly Hotchkiss, Mustafa Khasraw	2023	1
5	Characterization of industry relationships in oncology Cancer ·Rebecca A. Harrison, Nazanin Majd, Margaret Johnson, Diana L. Urbauer, Vinay K. Puduvalli, Mustafa Khasraw	2023	0
6	The Enduring Effects of COVID for Cancer Care: Learning from Real-Life Clinical Practice Clinical Cancer Research ·Alex Broom, Leah Williams Veazey, Katherine Kenny, Imogen Harper, Michelle Peterie, Alexander Page, Nicole Cort, Jennifer Durling, Eric Lipp, Aaron C. Tan, Kyle M. Walsh, Brent A. Hanks, Margaret Johnson, Amanda E.D. Van Swearingen, Carey K. Anders, David M. Ashley, Mustafa Khasraw	2023	7
7	Use, access, and initial outcomes of off-label ivosidenib in patients with IDH1 mutant glioma Neuro-Oncology Practice ·Katherine B. Peters, Candice Alford, Amy Heltemes, Alicia Savelli, Daniel Landi, Gloria Broadwater, Annick Desjardins, Margaret Johnson, Justin Low, Mustafa Khasraw, David M. Ashley, Henry S. Friedman, Mallika Patel	2023	11
8	Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement Clinical Cancer Research ·Stephen Bagley, Shawn Kothari, Rifaquat Rahman, Eudocia Q. Lee, Gavin P. Dunn, Evanthia Galanis, Susan M. Chang, Burt Nabors, Manmeet S. Ahluwalia, Roger Stupp, Minesh P. Mehta, David A. Reardon, Stuart A. Grossman, Erik P. Sulman, John H. Sampson, Simon Khagi, Michael Weller, Timothy F. Cloughesy, Patrick Y. Wen, Mustafa Khasraw	2021	104
9	Bintrafusp alfa (M7824), a bifunctional fusion protein targeting TGF-β and PD-L1: results from a phase I expansion cohort in patients with recurrent glioblastoma Neuro-Oncology Advances ·Mustafa Khasraw, Michael Weller, David Lorente, Kathryn S. Kolibaba, Chee Khoon Lee, Craig Gedye, Macarena I. de la Fuente, David Vicente, David A. Reardon, Hui Gan, Andrew M. Scott, Isabelle Dussault, Christoph Helwig, Laureen S. Ojalvo, Carole Gourmelon, Morris D. Groves	2021	18
10	PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma? Clinical Cancer Research ·Mustafa Khasraw, David A. Reardon, Michael Weller, John H. Sampson	2020	96
11	A RANDOMIZED PHASE II TRIAL OF VELIPARIB (V), RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN PATIENTS (PTS) WITH UNMETHYLATED MGMT (uMGMT) GLIOBLASTOMA (GBM): THE VERTU STUDY Neuro-Oncology ·Mustafa Khasraw, Kerrie L. McDonald, Mark Rosenthal, Zarnie Lwin, David M. Ashley, Helen Wheeler, Elizabeth Barnes, Matthew Foote, Eng‐Siew Koh, Erik P. Sulman, Michael Back, Michael E. Buckland, Hao‐Wen Sim, Lauren Fisher, Robyn Leonard, Merryn Hall, Sonia Yip, John Simes	2019	1
12	Defining the Supportive Care Needs and Psychological Morbidity of Patients With Functioning Versus Nonfunctioning Neuroendocrine Tumors: Protocol for a Phase 1 Trial of a Nurse-Led Online and Phone-Based Intervention JMIR Research Protocols ·Lisa Guccione, Karla Gough, Allison Drosdowsky, Krista Fisher, Timothy Price, Nick Pavlakis, Mustafa Khasraw, David Wyld, David Ransom, Grace Kong, Megan Rogers, Simone Leyden, John Leyden, Michael Michael, Penelope Schofield	2019	3
13	ATHENA (GOG-3020/ENGOT-ov45): A randomised, double-blind, placebo-controlled, phase 3 study of rucaparib plus nivolumab following front-line platinum-based chemotherapy in ovarian cancer Asia-Pacific Journal of Clinical Oncology ·Mustafa Khasraw, Kerrie L. McDonald, Sonia Yip, Roel G.W. Verhaak, Amy B. Heimberger, Merryn Hall, Lauren Fisher, Elizabeth Barnes, Mark Rosenthal, Craig Gedye, Elizabeth Hovey, Benjamin M. Ellingson, John Simes, Annette Tongela, Helen Wheeler, Eng‐Siew Koh, Hui Gan, Michael Back, Zarnie Lwin	2018	1
14	Pattern of care and survival of pancreatic ductal adenocarcinoma in a multi-disciplinary high-volume centre Gastroenterology & Hepatology Open Access ·Malinda Itchins, Jennifer Arena, Nick Pavlakis, Christopher B. Nahm, Emma Gibbs, Anthoulla Mohamudally, Richard Maher, L.L. Bailey, Geoffrey Schembri, Gill Aj, Connie I. Diakos, Mustafa Khasraw, George Hruby, Andrew Kneebone, Anita Mittal, Jas Samra, Sharon E. Clarke, Steven Blome, Gary N. Mann	2018	1
15	Outcomes after second surgery for recurrent glioblastoma: a retrospective case–control study Journal of Neuro-Oncology ·Alysson Wann, Patrick Tully, Elizabeth H Barnes, Zarnie Lwin, Rosalind L. Jeffree, Katharine J. Drummond, Hui Gan, Mustafa Khasraw	2018	51
16	Machine-learning prediction of cancer survival: a retrospective study using electronic administrative records and a cancer registry BMJ Open ·Sunil Gupta, Truyen Tran, Wei Luo, Dinh Phung, Richard L. Kennedy, A. Broad, David Campbell, David Kipp, Madhu Singh, Mustafa Khasraw, Leigh Matheson, David M. Ashley, Svetha Venkatesh	2014	83
17	THE ADDITION OF ANTI-ANGIOGENIC TYROSINE KINASE INHIBITORS TO CHEMOTHERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS Deakin Research Online (Deakin University) ·BT Li, Csilla Hasovits, A Lee, Ae Li, Mustafa Khasraw, Gavin Marx, Nick Pavlakis	2013	1
18	Emerging pharmacotherapy for cancer patients with cognitive dysfunction BMC Neurology ·Justin Davis, Fiona M Ahlberg, Michael Berk, David M. Ashley, Mustafa Khasraw	2013	27
19	SURVIVAL AND TREATMENT OF CRANIAL METASTASES (CMS) FROM NEUROENDOCRINE TUMORS (NETS) AT MEMORIAL SLOAN-KETTERING CANCER CENTER (MSKCC) Neuro-Oncology ·Mustafa Khasraw, Thomas Kaley, K. Panageas, Angelika Reiner, Sandra Goldlust, Tabar	2010	1
20	CHEMOTHERAPY IN THE ELDERLY Own your potential (DEAKIN) ·Mustafa Khasraw, Gavin Marx	2008	3

About Mustafa Khasraw

Mustafa Khasraw is a scholar working on Genetics, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Neurology, having authored 194 papers that have together received 5.8k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (83 papers), Brain Metastases and Treatment (46 papers), Cancer Genomics and Diagnostics (22 papers), Cancer Immunotherapy and Biomarkers (21 papers), Lung Cancer Research Studies (21 papers), Neuroblastoma Research and Treatments (18 papers), Lung Cancer Treatments and Mutations (14 papers) and PARP inhibition in cancer therapy (13 papers). The work is most often cited by research in Genetics (1.9k citations), Oncology (2.3k citations), Cancer Research (1.3k citations), Pulmonary and Respiratory Medicine (1.5k citations) and Immunology (956 citations). Mustafa Khasraw has collaborated with scholars based in Australia, United States and Singapore. Frequent co-authors include David M. Ashley, Aaron C. Tan, Henry S. Friedman, Giselle Y. López, Michael D. Malinzak, Brent A. Hanks, John H. Strickler, Nick Pavlakis, Andrew B. Lassman and Richard H. Bell. Their work appears in journals such as Neuro-Oncology, Journal of Clinical Oncology, Clinical Cancer Research, Cochrane Database of Systematic Reviews and Neuro-Oncology Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact